Re: Pfizer Viagra Research Grants Debbie Smith 13 Jan 2003 11:19 EST

Thanks, Joe.  We took a pass on it, too!

Debbie

----- Original Message -----
From: Joseph Broderick <xxxxxx@UMDNJ.EDU>
To: <xxxxxx@HRINET.ORG>
Sent: Monday, January 13, 2003 9:23 AM
Subject: Re: [RESADM-L] Pfizer Viagra Research Grants

Now that we are aware of the intellectual property condition of these
awards, we are not signing off on applications.

Joe

Debbie Smith wrote:

> I know there was some discussion about this last week, and now one has
> arrived at my door!
>
> What have other institutions decided to do about these Pfizer Viagra
> Research Grants that include the term that stipulates that Pfizer owns
> anything that comes out of it?
>
> Thanks!
>
> Debbie Smith
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================

--
Joseph B. Broderick
Grants and Contracts Administrator
Office of Research and Sponsored Programs
UMDNJ - Robert Wood Johnson Medical School
675 Hoes Lane, Room R109
Piscataway, NJ 08854
 Phone: 732/235-2158   Fax: 732/235-5534
 Website: http://www2.umdnj.edu/orspweb

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================